Gregg Goldfarb
January 22, 2024 | Daily Business Review
Too Good to Be True? Ozempic Lawsuit Moves Forward as Gastrointestinal Issues SurfaceOzempic isn't without side effects, however, and several patients who have experienced severe complications from the drug are now suing Novo Nordisk and Eli Lilly on allegations that the pharmaceutical companies misled doctors on the drugs' potential risks.
By Gregg Goldfarb
5 minute read
June 23, 2023 | Daily Business Review
The Massive Stakes of Anthony Valadez's Case Against Johnson & JohnsonThe outcome of a single asbestos case against J&J will influence an $8.9 billion settlement offer that could change mass torts forever.
By Gregg Goldfarb
5 minute read
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3'That's Disappointing': Only 11% of MDL Appointments Went to Attorneys of Color in 2023
- 4What We Know About the Kentucky Judge Killed in His Chambers
- 5'I'm Staying Everything': Texas Bankruptcy Judge Halts Talc Trials Against J&J
More from ALM
- Morgan & Morgan Class Action Attorneys Detail Pathway to Success Within Cybersecurity and Data Privacy Practice 1 minute read
- Holwell Shuster & Goldberg Partners Leverage 'Hostile' Witnesses to Secure $101 Million Verdict Against Walmart 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read